CytoDyn Investors Challenge Director Removal Rule In Del.
Two stockholders in late-stage biotech venture CytoDyn Inc. sued the company in Delaware Chancery Court late Wednesday in a challenge to the company's "for cause only" restriction on director removals, the...To view the full article, register now.
Already a subscriber? Click here to view full article